© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
June 24, 2021
At a median follow-up of almost two years, 88.5% of patients remained on study treatment.
February 15, 2021
Treatment with Padcev, compared to chemotherapy, continues to show better results in patients with advanced urothelial carcinoma who had previously received certain therapies.
October 31, 2018
Some women with hormone-driven early breast cancer can skip chemotherapy after surgery.
November 13, 2017
Treatment with Opdivo (nivolumab) plus Yervoy (ipilimumab) improved response rates in patients with melanoma, but not without some severe side effects.
Healthy Habits May Offset Genetic Cancer Risk
Expert Explains Prognosis Indicators, Treatment Plans in MCL
Smoking Cessation May Provide ‘Huge Benefit’ After Lung Cancer Diagnosis
The Game of Cancer